LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnerships Ayala Pharmaceuticals has a history of successful partnerships, such as merging with Advaxis Inc. and collaborating with Novartis International Pharmaceutical Limited. Leveraging these strategic partnerships can open doors to new sales channels and opportunities.

Acquisitions and Mergers Recent acquisitions like BioSight and asset sales to Immunome, Inc. demonstrate Ayala Pharmaceuticals' proactive approach to expanding its portfolio and market reach. Exploring collaboration opportunities with these newly acquired entities can lead to increased sales prospects.

Innovative Treatment Options Ayala Pharmaceuticals is developing groundbreaking treatments like AL102 for Desmoid Tumors and ADXS-504 for prostate cancer. Highlighting the innovative nature of these treatments can attract interest from healthcare providers and institutions seeking cutting-edge solutions.

Market Recognition Ayala Pharmaceuticals' partnerships with the FDA, successful clinical trials, and Fast Track Designation for AL102 showcase industry recognition and validation. Utilizing this market recognition in sales pitches can enhance credibility and foster trust among potential clients.

Diversified Product Portfolio With a focus on rare tumors, aggressive cancers, and common cancers, Ayala Pharmaceuticals offers a diversified product portfolio catering to various medical needs. Tailoring sales strategies to highlight the versatility of their product offerings can attract a wider range of customers.

Similar companies to Ayala Pharmaceuticals

Ayala Pharmaceuticals Tech Stack

Ayala Pharmaceuticals uses 8 technology products and services including W3 Total Cache, Cloudflare CDN, WordPress, and more. Explore Ayala Pharmaceuticals 's tech stack below.

  • W3 Total Cache
    Caching
  • Cloudflare CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • Open Graph
    Miscellaneous
  • WP Engine
    Platform As A Service
  • Cloudflare Bot Management
    Security

Media & News

Ayala Pharmaceuticals 's Email Address Formats

Ayala Pharmaceuticals uses at least 1 format(s):
Ayala Pharmaceuticals Email FormatsExamplePercentage
First.L@ayalapharma.comJohn.D@ayalapharma.com
50%
First.L@ayalapharma.comJohn.D@ayalapharma.com
50%

Frequently Asked Questions

Where is Ayala Pharmaceuticals 's headquarters located?

Minus sign iconPlus sign icon
Ayala Pharmaceuticals 's main headquarters is located at 1313 N Market St Wilmington, Delaware 19801 US. The company has employees across 2 continents, including AsiaNorth America.

What is Ayala Pharmaceuticals 's stock symbol?

Minus sign iconPlus sign icon
Ayala Pharmaceuticals is a publicly traded company; the company's stock symbol is ADXS.

What is Ayala Pharmaceuticals 's official website and social media links?

Minus sign iconPlus sign icon
Ayala Pharmaceuticals 's official website is ayalapharma.com and has social profiles on LinkedIn.

How much revenue does Ayala Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of March 2024, Ayala Pharmaceuticals 's annual revenue reached $3.5M.

What is Ayala Pharmaceuticals 's NAICS code?

Minus sign iconPlus sign icon
Ayala Pharmaceuticals 's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Ayala Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of March 2024, Ayala Pharmaceuticals has approximately 31 employees across 2 continents, including AsiaNorth America. Key team members include Chief Medical Officer: G. G.Chief Science Officer: S. T.Vice President Clinical Operations: Y. L. B.. Explore Ayala Pharmaceuticals 's employee directory with LeadIQ.

What industry does Ayala Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Ayala Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Ayala Pharmaceuticals use?

Minus sign iconPlus sign icon
Ayala Pharmaceuticals 's tech stack includes W3 Total CacheCloudflare CDNWordPressMySQLFont AwesomeOpen GraphWP EngineCloudflare Bot Management.

What is Ayala Pharmaceuticals 's email format?

Minus sign iconPlus sign icon
Ayala Pharmaceuticals 's email format typically follows the pattern of . Find more Ayala Pharmaceuticals email formats with LeadIQ.

How much funding has Ayala Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of March 2024, Ayala Pharmaceuticals has raised $25M in funding. The last funding round occurred on Feb 19, 2021 for $25M.

When was Ayala Pharmaceuticals founded?

Minus sign iconPlus sign icon
Ayala Pharmaceuticals was founded in 2017.
Ayala Pharmaceuticals

Ayala Pharmaceuticals

Pharmaceutical ManufacturingDelaware, United States11-50 Employees

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. We are also developing proprietary Lm-based antigen delivery products for patients suffering from more common cancers. Our lead candidates under development are the oral gamma secretase inhibitor, AL102, for desmoid tumors; ADXS-504, a Lm-based therapy for early-stage prostate cancer, and the intravenous gamma secretase inhibitor, AL101, for adenoid cystic carcinoma. AL102 (RINGSIDE) has received Fast Track Designation from the U.S. FDA and is currently in the Phase 3 segment of a pivotal study for patients with desmoid tumors.

Section iconCompany Overview

Headquarters
1313 N Market St Wilmington, Delaware 19801 US
Stock Symbol
ADXS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $25M

    Ayala Pharmaceuticals has raised a total of $25M of funding over 4 rounds. Their latest funding round was raised on Feb 19, 2021 in the amount of $25M.

  • $10M

    Ayala Pharmaceuticals 's revenue is in the range of $10M

Section iconFunding & Financials

  • $25M

    Ayala Pharmaceuticals has raised a total of $25M of funding over 4 rounds. Their latest funding round was raised on Feb 19, 2021 in the amount of $25M.

  • $10M

    Ayala Pharmaceuticals 's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.